Binding of the asymmetric forms of acetylcholinesterase to heparin.

PubWeight™: 0.90‹?›

🔗 View Article (PMC 1144053)

Published in Biochem J on July 15, 1984

Authors

E Brandan, N C Inestrosa

Articles cited by this

A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol (1961) 45.34

Cell surface interactions with extracellular materials. Annu Rev Biochem (1983) 6.76

PURIFICATION, COMPOSITION, AND MOLECULAR WEIGHT OF THE BETA-GALACTOSIDASE OF ESCHERICHIA COLI K12. J Biol Chem (1965) 5.98

Reinnervation of muscle fiber basal lamina after removal of myofibers. Differentiation of regenerating axons at original synaptic sites. J Cell Biol (1978) 2.78

Cholinesterase is associated with the basal lamina at the neuromuscular junction. Nature (1978) 2.18

Laminin, fibronectin, and collagen in synaptic and extrasynaptic portions of muscle fiber basement membrane. J Cell Biol (1982) 2.10

Multiple forms of acetylcholinesterase and their distribution in endplate and non-endplate regions of rat diaphragm muscle. J Neurobiol (1973) 1.91

Heparin-lipoprotein lipase interactions. Fed Proc (1977) 1.87

Evidence for an ionic binding of lipoprotein lipase to heparin. Biochem Biophys Res Commun (1971) 1.32

Asymmetric and globular forms of acetylcholinesterase in mammals and birds. Proc Natl Acad Sci U S A (1979) 1.30

Roles of extracellular matrix in neural development. Annu Rev Physiol (1983) 1.19

Cross-linking and binding of fibronectin with asymmetric acetylcholinesterase. Biochemistry (1981) 1.16

The dependence of acetylcholinesterase aggregation at low ionic strength upon a polyanionic component. Eur J Biochem (1978) 1.14

Divalent cation modulation of fibronectin binding to heparin and to DNA. J Biol Chem (1982) 1.12

Cellular localization of the molecular forms of acetylcholinesterase in rat diaphragm. J Biol Chem (1982) 1.11

Interactions of asymmetric forms of acetylcholinesterase with basement membrane components. J Biol Chem (1983) 1.07

Association of the synaptic form of acetylcholinesterase with extracellular matrix in cultured mouse muscle cells. Cell (1982) 1.06

Heparin solubilizes asymmetric acetylcholinesterase from rat neuromuscular junction. FEBS Lett (1983) 0.88

Cellular localization of the molecular forms of acetylcholinesterase in rat pheochromocytoma PC12 cells treated with nerve growth factor. J Neurosci (1981) 0.88

Relationship of collagen-tailed acetylcholinesterase with basal lamina components. Absence of binding with laminin, fibronectin, and collagen types IV and V and lack of reactivity with different anti-collagen sera. Eur J Biochem (1983) 0.86

The A12 acetylcholinesterase and polypeptide composition of electric organ basal lamina of Electrophorus and some Torpedinae fishes. Cell Biochem Funct (1983) 0.85

Heparan sulphate and the binding of lipoprotein lipase to porcine thoracic aorta endothelium. Biochim Biophys Acta (1983) 0.83

16S acetylcholinesterase of the extracellular matrix is assembled within mouse muscle cells in culture. Biochem J (1984) 0.83

Neural 16S acetylcholinesterase is solubilized by heparin. Biochem J (1983) 0.82

Acetylcholinesterase like that of skeletal muscle in smooth muscle reinnervated by a motor nerve. Nature (1979) 0.80

Articles by these authors

Wnt signaling function in Alzheimer's disease. Brain Res Brain Res Rev (2000) 1.64

Activation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by beta-amyloid fibrils. Mol Psychiatry (2003) 1.47

Detection of peroxisomal fatty acyl-coenzyme A oxidase activity. Biochem J (1979) 1.44

Thioflavin T is a fluorescent probe of the acetylcholinesterase peripheral site that reveals conformational interactions between the peripheral and acylation sites. J Biol Chem (2001) 1.40

Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1DeltaE9 mouse model of Alzheimer's disease. Mol Psychiatry (2009) 1.34

Developmental regulation of 16S acetylcholinesterase and acetylcholine receptors in a mouse muscle cell line. Exp Cell Res (1983) 1.34

The alpha-helical to beta-strand transition in the amino-terminal fragment of the amyloid beta-peptide modulates amyloid formation. J Biol Chem (1995) 1.27

Platelets are the primary source of amyloid beta-peptide in human blood. Biochem Biophys Res Commun (1995) 1.19

Fatty acid oxidation by human liver peroxisomes. Biochem Biophys Res Commun (1979) 1.18

Orientation and role of nucleosidediphosphatase and 5'-nucleotidase in Golgi vesicles from rat liver. Biochemistry (1982) 1.16

Acetylcholinesterase from bovine caudate nucleus is attached to membranes by a novel subunit distinct from those of acetylcholinesterases in other tissues. J Biol Chem (1987) 1.15

Anchorage of collagen-tailed acetylcholinesterase to the extracellular matrix is mediated by heparan sulfate proteoglycans. J Cell Biol (1985) 1.13

Aneural muscle cell cultures make synaptic basal lamina components. Nature (1982) 1.11

Two heparin-binding domains are present on the collagenic tail of asymmetric acetylcholinesterase. J Biol Chem (1995) 1.10

Purification of the peroxisomal fatty acyl-CoA oxidase from rat liver. Biochem Biophys Res Commun (1980) 1.10

Decorin core protein fragment Leu155-Val260 interacts with TGF-beta but does not compete for decorin binding to type I collagen. Arch Biochem Biophys (1998) 1.09

Acetylcholinesterase promotes the aggregation of amyloid-beta-peptide fragments by forming a complex with the growing fibrils. J Mol Biol (1997) 1.06

Association of the synaptic form of acetylcholinesterase with extracellular matrix in cultured mouse muscle cells. Cell (1982) 1.06

The role of oxidative stress in the toxicity induced by amyloid beta-peptide in Alzheimer's disease. Prog Neurobiol (2000) 1.04

Expression of alpha(2)-macroglobulin receptor/low density lipoprotein receptor-related protein (LRP) in rat microglial cells. J Neurosci Res (2000) 1.03

Stable complexes involving acetylcholinesterase and amyloid-beta peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer's fibrils. J Neurosci (1998) 1.03

Antisense inhibition of decorin expression in myoblasts decreases cell responsiveness to transforming growth factor beta and accelerates skeletal muscle differentiation. J Biol Chem (2000) 0.98

Hyperforin prevents beta-amyloid neurotoxicity and spatial memory impairments by disaggregation of Alzheimer's amyloid-beta-deposits. Mol Psychiatry (2006) 0.98

Mannose receptor is present in a functional state in rat microglial cells. J Neurosci Res (1999) 0.98

Structural determinants of the Alzheimer's amyloid beta-peptide. J Neurochem (1994) 0.98

Acyl-CoA synthetase and the peroxisomal enzymes of beta-oxidation in human liver. Quantitative analysis of their subcellular localization. Biochem J (1984) 0.97

A structural motif of acetylcholinesterase that promotes amyloid beta-peptide fibril formation. Biochemistry (2001) 0.96

Beta-sheet breaker peptide prevents Abeta-induced spatial memory impairments with partial reduction of amyloid deposits. Mol Psychiatry (2004) 0.94

Extracellular matrix is required for skeletal muscle differentiation but not myogenin expression. J Cell Biochem (1996) 0.93

Acetylcholinesterase is a senile plaque component that promotes assembly of amyloid beta-peptide into Alzheimer's filaments. Mol Psychiatry (1996) 0.91

Expression and localization of proteoglycans during limb myogenic activation. Dev Dyn (2001) 0.90

Interaction between Alzheimer's disease beta A4 precursor protein (APP) and the extracellular matrix: evidence for the participation of heparan sulfate proteoglycans. J Cell Biochem (1997) 0.90

Axonal sprouting induced in the sciatic nerve by the amyloid precursor protein (APP) and other antiproteases. Neurosci Lett (1992) 0.90

Syndecan-1 expression is down-regulated during myoblast terminal differentiation. Modulation by growth factors and retinoic acid. J Biol Chem (1997) 0.89

Antisense inhibition of syndecan-3 expression during skeletal muscle differentiation accelerates myogenesis through a basic fibroblast growth factor-dependent mechanism. J Biol Chem (1999) 0.89

Heparin solubilizes asymmetric acetylcholinesterase from rat neuromuscular junction. FEBS Lett (1983) 0.88

Role of axoplasmic transport in neurotrophic regulation of muscle end plate acetylcholinesterase. Nature (1976) 0.88

Subcellular fractionation studies on the organization of fatty acid oxidation by liver peroxisomes. Ann N Y Acad Sci (1982) 0.88

Interaction of the collagen-like tail of asymmetric acetylcholinesterase with heparin depends on triple-helical conformation, sequence and stability. Biochem J (2000) 0.88

Isolation and purification of human biliary vesicles with potent cholesterol-nucleation-promoting activity. Clin Sci (Lond) (1992) 0.88

Cellular localization of the molecular forms of acetylcholinesterase in rat pheochromocytoma PC12 cells treated with nerve growth factor. J Neurosci (1981) 0.88

Neurotoxicity of acetylcholinesterase amyloid beta-peptide aggregates is dependent on the type of Abeta peptide and the AChE concentration present in the complexes. FEBS Lett (1999) 0.88

Isolation and partial characterization of cholesterol pronucleating hydrophobic glycoproteins associated to native biliary vesicles. FEBS Lett (1993) 0.87

Synthesis of proteoglycans is augmented in dystrophic mdx mouse skeletal muscle. Eur J Cell Biol (2000) 0.86

The N-terminal tandem repeat region of human prion protein reduces copper: role of tryptophan residues. Biochem Biophys Res Commun (2000) 0.86

Sprouting and abnormal contacts of nonmedullated axons, and deposition of extracellular material induced by the amyloid precursor protein (APP) and other protease inhibitors. Brain Res (1996) 0.86

PC12 and neuro 2a cells have different susceptibilities to acetylcholinesterase-amyloid complexes, amyloid25-35 fragment, glutamate, and hydrogen peroxide. J Neurosci Res (1999) 0.85

The A12 acetylcholinesterase and polypeptide composition of electric organ basal lamina of Electrophorus and some Torpedinae fishes. Cell Biochem Funct (1983) 0.85

Neurobiological effects of Hyperforin and its potential in Alzheimer's disease therapy. Curr Med Chem (2010) 0.85

Interactions of laminin with the amyloid beta peptide. Implications for Alzheimer's disease. Braz J Med Biol Res (2001) 0.84

Distribution and anchoring of molecular forms of acetylcholinesterase. Trends Pharmacol Sci (1989) 0.84

Syndecan-1 expression inhibits myoblast differentiation through a basic fibroblast growth factor-dependent mechanism. J Biol Chem (1998) 0.84

Properties of fatty acyl-CoA oxidase from rat liver, a peroxisomal flavoprotein. Life Sci (1979) 0.84

Ethodin: pharmacological evidence of the interaction between smooth muscle and mast cells in the myometrium. J Pharmacol Exp Ther (1997) 0.83

Subcellular localization of acetylcholinesterase molecular forms in endplate regions of adult mammalian skeletal muscle. Neurochem Res (1984) 0.83

Atypical distribution of asymmetric acetylcholinesterase in mutant PC12 pheochromocytoma cells lacking a cell surface heparan sulfate proteoglycan. J Neurochem (1985) 0.83

Toxic effects of acetylcholinesterase on neuronal and glial-like cells in vitro. Mol Psychiatry (1998) 0.83

16S acetylcholinesterase of the extracellular matrix is assembled within mouse muscle cells in culture. Biochem J (1984) 0.83

Acetylcholinesterase is functional in embryonic rat muscle before its accumulation at the sites of nerve-muscle contact. Dev Biol (1984) 0.82

Neural 16S acetylcholinesterase is solubilized by heparin. Biochem J (1983) 0.82

A human prion protein peptide (PrP(59-91)) protects against copper neurotoxicity. Mol Psychiatry (2003) 0.82

Isolation of the heparan sulfate proteoglycans from the extracellular matrix of rat skeletal muscle. J Neurobiol (1987) 0.82

Tetrameric (G4) acetylcholinesterase: structure, localization, and physiological regulation. J Neurochem (1996) 0.82

Expression of perlecan, a proteoglycan that binds myogenic inhibitory basic fibroblast growth factor, is down regulated during skeletal muscle differentiation. Exp Cell Res (1997) 0.82

Acetylcholinesterase changes in hearts with sinus rhythm and atrial fibrillation. Gen Pharmacol (1993) 0.81

Synthesis and expression of functional angiotensin II receptors in Xenopus oocytes injected with rat brain mRNA. Brain Res (1987) 0.81

Mitosis of Schwann cells and demyelination are induced by the amyloid precursor protein and other protease inhibitors in the rat sciatic nerve. Eur J Neurosci (1995) 0.81

Laminin inhibits amyloid-beta-peptide fibrillation. Neurosci Lett (1996) 0.80

Cysteine 144 is a key residue in the copper reduction by the beta-amyloid precursor protein. J Neurochem (1999) 0.80

Proteoglycan production in Drosophila egg development: effect of beta-D-xyloside on proteoglycan synthesis and larvae motility. Comp Biochem Physiol B (1990) 0.80

Acetylcholinesterase like that of skeletal muscle in smooth muscle reinnervated by a motor nerve. Nature (1979) 0.80

Extracellular matrix components and amyloid in neuritic plaques of Alzheimer's disease. Gen Pharmacol (1993) 0.80

Laminin blocks the assembly of wild-type A beta and the Dutch variant peptide into Alzheimer's fibrils. Amyloid (1998) 0.80

Characterization of a tetrameric G4 form of acetylcholinesterase from bovine brain: a comparison with the dimeric G2 form of the electric organ. Mol Cell Biochem (1988) 0.80

A major portion of synaptic basal lamina acetylcholinesterase is detached by high salt- and heparin-containing buffers from rat diaphragm muscle and Torpedo electric organ. J Biol Chem (1998) 0.80

At least two receptors of asymmetric acetylcholinesterase are present at the synaptic basal lamina of Torpedo electric organ. Biochem Biophys Res Commun (1998) 0.79

Differential association and distribution of acetyl- and butyrylcholinesterases within rat liver subcellular organelles. J Biol Chem (1990) 0.79

A monoclonal antibody against acetylcholinesterase inhibits the formation of amyloid fibrils induced by the enzyme. Biochem Biophys Res Commun (1997) 0.79

Effects of denervation and of axoplasmic transport blockage on the in vitro release of muscle endplate acetylcholinesterase. J Neurochem (1977) 0.79

Acetylcholinesterase, a senile plaque component, affects the fibrillogenesis of amyloid-beta-peptides. Neurosci Lett (1995) 0.79

A lipid-anchored heparan sulfate proteoglycan is present in the surface of differentiated skeletal muscle cells. Isolation and biochemical characterization. Eur J Biochem (1993) 0.79

Peripheral binding site is involved in the neurotrophic activity of acetylcholinesterase. Neuroreport (1999) 0.78

Decorin is specifically solubilized by heparin from the extracellular matrix of rat skeletal muscles. FEBS Lett (1993) 0.78

Amyloid precursor protein fragment and acetylcholinesterase increase with cell confluence and differentiation in a neuronal cell line. Exp Cell Res (1996) 0.78

Membrane-bound form of acetylcholinesterase activated during postnatal development of the rat somatosensory cortex. Dev Neurosci (1985) 0.78

Early axonal regeneration: repression by Schwann cells and a protease? Exp Neurol (1995) 0.78

Estrogen protects neuronal cells from the cytotoxicity induced by acetylcholinesterase-amyloid complexes. FEBS Lett (1998) 0.78

A 13 kDa fragment is responsible for the hydrophobic aggregation of brain G4 acetylcholinesterase. Biochem J (1988) 0.78

Amyloid-beta-peptide reduces copper(II) to copper(I) independent of its aggregation state. Biol Res (2000) 0.78

Golgi complex function in the excretion of renal kallikrein (41502). Proc Soc Exp Biol Med (1982) 0.78

Interaction of skeletal muscle cells with collagen type IV is mediated by perlecan associated with the cell surface. J Cell Biochem (1999) 0.77

Interaction of heparin with multimolecular aggregates of acetylcholinesterase. Cell Mol Neurobiol (1985) 0.77

Developmental regulation of mouse brain monomeric acetylcholinesterase. Int J Dev Neurosci (1998) 0.77

Effect of protamine on the solubilization of collagen-tailed acetylcholinesterase: potential heparin-binding consensus sequences in the tail of the enzyme. Biochim Biophys Acta (1995) 0.77

Brain acetylcholinesterase promotes amyloid-beta-peptide aggregation but does not hydrolyze amyloid precursor protein peptides. Neurochem Res (1998) 0.77

Isolation and characterization of coated vesicles from rat liver. Methods Enzymol (1983) 0.77